Theme: Leading Innovations and Approaches towards Stress Management, Anxiety and Depression

Stress Meet 2020

Stress Meet 2020

On behalf of Organizing Committee we invite all the participants from all part of the world to attend “International Summit on Depression, Anxiety and Stress Management” scheduled during August 10-11, 2020 through Webinar.

Stress Meet 2020 conference is the leading meeting dedicated to Psychiatrists and Stress researchers with the theme “Leading Innovations and Approaches towards Stress Management, Anxiety and Depression”. The goal is to deliver an outstanding program for exchange of ideas and authoritative views by leading scientists which covers the entire spectrum of research in Stress, Anxiety, and Depression and share the cross-cultural experiences of various treatment procedures.

This meeting is for Psychiatrists as well as Stress committees to discuss the future of the Stress and Psychiatry in terms of collaboration, structures and organizational development and advances of Stress and Psychological syndromes. The leading cause of disability is depression, Globally 350 million people suffer from depression. Problems due to depression are reported as the primary disability factor worldwide, causing nearly 40 million years of disability in people aged 20- 29 years. Factors like age, gender, and lifestyle contribute towards a person’s mental ill health development. Some people are even experiencing more than one mental health disorders. It shows that how common certain condition in all over world gives a picture of mental health across our lifetime i.e. from childhood to teenage, working age, adults to older.


Why to attend?

This Stress Meet 2020 conference with your support and high quality talks from both Psychiatrists as well as Psychological committees. During the conference, we assure you that you will experience world class facilities and hospitality at the conference.

International Conference on Depression, Anxiety and Stress Management is a unique forum to bring together worldwide distinguished academics in the field of Psychology and Psychiatry, Stress researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies. The Conference will feature many exciting academic programs including multiple panels, workshops, affinity group lunches, paper presentations, and scientific sessions by reputed psychiatrists from all over the country.


Target Audience:

  • Psychiatrists
  • Physicians
  • Psychologists
  • Specialists
  • Researchers
  • Health care professionals
  • Professors
  • Industrial Experts
  • Neuropsychiatrists
  • Mental health Nurses
  • Nutritional Scientists
  • Lecturers and Students from Academia
  • Students from Academia in the research of Psychology


Market Analysis

Stress, Depression treatment and Anxiety disorder Market value $17.4 Billion by 2022. According to a report, the world anxiety disorders and depression treatment market can demonstrate a mediocre CAGR of two.75% throughout the forecast amount from 2017 to 2022. In 2015, the world anxiety disorders and depression treatment market stood at £22.5 billion in 2015 and is projected to achieve £18.2 billion by a pair of 2020. According to World Health Organization, presently UK is calculable 300 million people globally are affected with depression, anxiety and stress. The first driver of the world anxiety disorders and depression treatment market is that the fast prevalence of depression and anxiety disorders. Other factors driving the world anxiety disorders and depression treatment market are rising geriatric population and increasing affectivity and decreasing facet effects of medicine in many categories. Depression moves 10 to 15 men and regarding 15 to 25 women. According to the World Health Organization (WHO), to date, over 300 million people are stricken by depression globally. The Anxiety and Depression Association of America disclosed that at this time some 35 million people within the UK are plagued by mental disorder and treating these patients prices around £40 billion every year. Nearly 55% of the ladies with early carcinoma had depression, anxiety, stressed or each within the year once identification, 28% within the 2nd, 3rd, and 4th years, and 25% within the 5th year. 49% of these with return intimate Stress, Depression treatment and Anxiety disorder, or each inside 3 months of the documentation. The annual prevalence’s for the major to 50 years once identification were 45%, 22%, 20%, 19%, and 12%, severally.

Global Mental Health Funders:

  • Grand Challenges in Global Mental Health, USA
  • Grand Challenges Canada
  • National Institute of Mental health
  • Department for International Development, UK

Major Global Societies and Associations:

  • World Psychiatric Association
  • American Psychiatric Association
  • European Psychiatric Association
  • European Federation of Psychiatric Trainees
  • National Institute of Mental Health
  • The World Federation for Mental Health
  • European Network for Workplace Health Promotion
  • National Research and Development Centre for Welfare and Health (STAKES)
  • European Alliance against Depression
  • World Health Organisation
  • Professional association of German psychologists


To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date August 10-11, 2020
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2
Poster Opportunity Closed Click Here to View